The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

If you're struggling with chronic low back pain, then this is for you. Brad: So we're going to show you three different ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

Other research has shown red light therapy could minimize the appearance of wrinkles, hyperpigmentation, and broken blood ...

A pilot trial will assess whether concentrated bone marrow aspirate can prevent inflammation and reduce postsurgery pain and ...

A recent treatment is offering hope to people suffering from knee pain, especially those over the age of 50. Researchers at MedStar Georgetown University Hospital found that a minimally invasive ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

For active New Orleanians, knee osteoarthritis (OA) pain can sideline even the most passionate participants. Whether it’s ...